Oxidized, Regenerated Cellulose Adhesion Barrier Plus Intrauterine Device Prevents Recurrence After Adhesiolysis for Moderate to Severe Intrauterine Adhesions-Reference-Cited by-同舟云学术

Oxidized, Regenerated Cellulose Adhesion Barrier Plus Intrauterine Device Prevents Recurrence After Adhesiolysis for Moderate to Severe Intrauterine Adhesions

Published:2017-01 Issue:1 Volume:24 Page:80-88
ISSN:1553-4650
Container-title:Journal of Minimally Invasive Gynecology
language:en
Short-container-title:Journal of Minimally Invasive Gynecology

Author:

Cai Huihua,Qiao Lin,Song KaiJing,He Yuanli

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference26 articles.

1. Asherman syndrome–one century later;Yu;Fertil Steril,2008

2. Intrauterine adhesions: an updated appraisal;Schenker;Fertil Steril,1982

3. Efficacy of estrogen therapy in patients with intrauterine adhesions: systematic review;Johary;J Minim Invasive Gynecol,2014

4. AAGL practice report: practice guidelines for management of intrauterine synechiae;J Minim Invasive Gynecol,2010

5. A comparison of two adjunctive treatments for intrauterine adhesions following lysis;Orhue;Int J Gynaecol Obstet,2003

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of laparoscopic surgery for removal of an intrauterine device that migrated into the uterine myometrium;JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY;2024

2. Chitosan combined with intrauterine device prevents intrauterine adhesions after hysteroscopic adhesiolysis: A target trial emulation study;Journal of Obstetrics and Gynaecology Research;2023-03-04

3. Research progress of biopolymers combined with stem cells in the repair of intrauterine adhesions;Nanotechnology Reviews;2023-01-01

4. Comparison of the Effects of Hysteroscopic Cold Broad Sword Play Combined with Estrogen and Progestin Sequential Therapy and Drospirenone and Ethinylestradiol Tablets in Patients with Severe Intrauterine Adhesion;Emergency Medicine International;2022-07-31

5. C-X-C Chemokine Receptor Type 4 (CXCR-4) Selective Allosteric Agonist ATI2341 TFA Promotes Uterine Repair in Asherman Syndrome;Journal of Biomaterials and Tissue Engineering;2022-07-01